Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”JAZZ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Epidiolex (Epidyolex in the EU
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] This morning (November 16),
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced this week
Denmark’s medical cannabis Pilot Programme has seen patient numbers grow by more than 90% between Q2 2022 and Q2 2023.
Apollon Formularies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”APOL.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis-listed Apollon Formularies has entered
Cannovum Cannabis AG [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”27N.DU” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German listed cannabis operator
DANISH medical cannabis operator Stenocare has published a flurry of operational updates over the past month as it hopes to
The new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM)
Stenocare This week the Danish medical cannabis company unveiled its unaudited Q4 and full year results, seeing sales more than
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15. The
SIGNIFICANT developments from Germany this week helped add to the momentum of interest in cannabis stocks initially driven by President
Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May
AFTER securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and
STENOCARE has seen double digit price rises across both the Copenhagen NASDAQ and the Frankfurt Stock Exchange, jumping 17.5% and
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears
STENOCARE A/S (“STENOCARE”) to make medical cannabis oil products available for UK patients. With this STENOCARE is taking a major step towards its goal of
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is
We won’t spam you
